Building Possibilities
BuildingPossibilities
Mission
Medad Technology is dedicated to developing novel therapeutic solutions that are smarter, safer and more effective for the prevention and treatment of chronic conditions. We are committed to improving public health and quality of life through scientific excellence and integrity. We are not just imagining the possibilities. We are building them.
HIGHLIGHTS
Medad Technology's ultrasonic delivery system demonstrates superior performance in latest clinical study.
Carbonyl emissions are below limits of detection with ultrasound technology for nicotine delivery, reducing potential harm for adult smokers.
Medad Technology's commitment to innovation is reflected in its portfolio of 331 patents and the development of 4 proprietary chips, accounting for 39% of all IP applications from the UAE.
Medad Technology harnesses the innovative spirit of the UAE by obtaining medical license for local R&D and manufacturing facility.
Who We Are
Medad Technology stands at the forefront of HealthTech innovation, having invested 4 years and $150 million in R&D to develop an ultrasonic delivery system that revolutionizes inhalation technology. Our system overcomes the limitations of traditional aerosol delivery, offering groundbreaking applications in both Consumer HealthTech and Pharmaceutical HealthTech sectors.
WHERE WE FOCUS
Consumer HealthTech
Pharmaceutical HealthTech
Power Management
Consumer HealthTech
Pharmaceutical HealthTech
Power Management
Utilizing ultrasound to remove the need for heat in nicotine delivery, to provide adult smokers with a potentially reduced-harm alternative.
Utilizing ultrasound to remove the need for heat in nicotine delivery, to provide adult smokers with a potentially reduced-harm alternative.
WHAT WE BUILD
Medad Technology's ultrasonic delivery system is built on 3 proprietary electronic components and an advanced in-house developed software. It consists of a Bluetooth enabled device, a disposable drug-containing pod and a mobile app. The app monitors usage data for dose control and behaviourial therapy support.
The core techology works under a Resonant Drive System (RDS) method, for which the natural frequency-finding electronics and algorithm were developed. The algorithm works seamlessly with the electronics to form a feedback loop that looks for the resonant point at the start of each inhalation, for optimal aerosol delivery efficiency.
Stay Updated
Receive the latest from Medad Technology—subscribe here for updates on our HealthTech solutions and advancements.